Study number 779857
Dates
Apr 21 2026-Jul 01 2026
Location
Daytona Beach, Florida
Age
18-65
Gender
Male OR Female
Smoker
Yes
Compensation
$12,049
Group
Cohort 2 OR 5
This is a research study for a drug approved by the U.S Food and Drug Administration (FDA) for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease.
Daytona Beach, FL is currently recruiting Healthy Adults, ages 18-65.
Refer a friend & receive $350 per qualified referral
Women Eligibility Criteria
Smoking Criteria
Body Mass Index
Screening procedures
Call Now to Schedule Your Screening Appointment!
Cohort 2:
Check-in: Apr 21
Check-out: Apr 22
Follow up Visits: Apr 24, 26, 29, May 2, 6, 13, 20, Jun 3, 17, Jul 1
Phone Calls: May 27, Jun 10, 24
OR
Cohort 5:
Check-in: Apr 30
Check-out: May 1
Follow up Visits: May 3, 5, 8, 11, 15, 22, 29 Jun 12, 26, Jul 10
Phone Calls: Jun 5, 19, Jul 3